As I said before, the merger, valued JNCE at less than cash value and the IP is more or less worthless (CVR), makes no sense. One major shareholder thought so too and offered cash value + CVR for the company and take it private. JNCE is now in play and GILD could buy the whole company for less than what they paid for one drug.
Wow! Unexpected positive news from our ridiculously cheap company. Wouldn't be surprised to see a 100% bump tomorrow. The joint merger could send this to the moon. All of a sudden, I am truly excited about owning this stock.$Jounce Therapeutics Inc.(JNCE)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments